Sleep quality measured by actigraphy-based wearable in rheumatoid arthritis patients treated with upadacitinib in a Swiss cohort
Introduction: Sleep impairment is a clinically significant burden in rheumatoid arthritis (RA) [ref:1]. Upadacitinib (UPA), a selective JAK inhibitor, has previously shown a positive impact on subjective sleep measures [ref:2]. However, objective sleep quality using wearables has [for full text, please go to the a.m. URL]
Institutions
- University of Fribourg (CH)
- University of St.Gallen (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Fribourg Development Agency (CH)
- Reha Rheinfelden (CH)
- ABB (Switzerland) (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-09-18
- DOI
- https://doi.org/10.3205/24dgrh163
- Primary Topic
- Plant Ecology and Soil Science
- Type
- article
- Field-Weighted Citation Impact
- 0.00